Tektronix Component Solutions, Vanguard sign Joint Marketing Agreement for microelectronics

NewsGuard 100/100 Score

Vanguard EMS and Tektronix Component Solutions have signed a Joint Marketing Agreement to formalize their collaboration and the joint offering of their capabilities to customers in the defense, aerospace, medical and industrial equipment markets. While companies in these markets frequently seek to control costs through outsourced manufacturing, finding suitable suppliers can be challenging due to the high-complexity and high-reliability requirements of their products.  Through the collaboration of Vanguard EMS, a high-reliability electronics manufacturing service provider, and Tektronix Component Solutions, customers now have access to the engineering, manufacturing and test services needed to support their assembly requirements from the microelectronics level to final system build and test.  

"Both companies have significant alignment in our business philosophies, emphasis on quality, culture, and, most importantly, how we serve customers," states Floyd Sutz, chief executive officer, Vanguard EMS.  "We are very excited about the Joint Marketing Agreement with Tektronix Component Solutions and believe the services we jointly provide will be a significant benefit for our customers."

Tom Buzak, president, Tektronix Component Solutions adds, "With Vanguard's focus on turnkey Printed Circuit Board (PCB) assembly, system integration and test, and our breadth of capabilities in microelectronics component design, assembly and test, we believe the combined offerings will be a significant value to our customers.  We are very enthusiastic about the opportunity to collaborate with Vanguard to provide a broader solution."

Source:

Vanguard EMS

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MD Anderson and CureVac collaborate on mRNA-based cancer vaccines